Literature DB >> 10736084

Quality of sedation during mechanical ventilation.

S D Playfor1, D A Thomas, I Choonara, A Jarvis.   

Abstract

The aim of the study was to determine the quality of sedation in ventilated patients on a general paediatric intensive care unit (PICU), including those treated with infusions of neuromuscular blocking agents. Twenty-eight ventilated children on a PICU had their level of sedation determined using an arousability scale dependent upon the response to tracheal suction. Observed levels of sedation were then compared to a predetermined desired level of sedation. A total of 81 assessments were performed and 90% were considered satisfactory. Thirty-two of these assessments were performed in 15 children following the temporary discontinuation of infusions of neuromuscular blocking agents; 97% of these assessments were considered satisfactory. A regime of continuous intravenous midazolam and morphine with additional oral sedation using chloral hydrate and antihistamines when required provides a satisfactory level of sedation for the majority of children ventilated on a PICU, including those treated with infusions of neuromuscular blocking agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736084     DOI: 10.1046/j.1460-9592.2000.00477.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

1.  State Behavioral Scale: a sedation assessment instrument for infants and young children supported on mechanical ventilation.

Authors:  Martha A Q Curley; Sion Kim Harris; Karen A Fraser; Rita A Johnson; John H Arnold
Journal:  Pediatr Crit Care Med       Date:  2006-03       Impact factor: 3.624

Review 2.  Optimal sedation in pediatric intensive care patients: a systematic review.

Authors:  Nienke J Vet; Erwin Ista; Saskia N de Wildt; Monique van Dijk; Dick Tibboel; Matthijs de Hoog
Journal:  Intensive Care Med       Date:  2013-06-19       Impact factor: 17.440

Review 3.  The role of systematic reviews in pharmacovigilance planning and Clinical Trials Authorisation application: example from the SLEEPS trial.

Authors:  Carrol Gamble; Andrew Wolf; Ian Sinha; Catherine Spowart; Paula Williamson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.